Trials / Completed
CompletedNCT00600951
Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease
A Prospective Cohort Study Evaluating the Incidence of Nephrogenic Systemic Fibrosis in Patients With Stages 3 to 5 Chronic Kidney Disease Undergoing MRI With the Injection of MultiHance
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 366 (actual)
- Sponsor
- Bracco Diagnostics, Inc · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of this long-term study is to prospectively compare the incidence of NSF in two cohorts (Cohort 1 - patients with moderate chronic kidney disease eGFR 30 to 59 and Cohort 2 - patients with severe chronic kidney disease or kidney failure eGFR \<30).
Conditions
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2008-01-25
- Last updated
- 2014-11-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00600951. Inclusion in this directory is not an endorsement.